MIRA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRA and other ETFs, options, and stocks.

About MIRA

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. 

CEO
Erez Aminov
CEOErez Aminov
Employees
5
Employees5
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2020
Founded2020
Employees
5
Employees5

MIRA Key Statistics

Market cap
61.26M
Market cap61.26M
Price-Earnings ratio
-0.96
Price-Earnings ratio-0.96
Dividend yield
Dividend yield
Average volume
126.48K
Average volume126.48K
High today
$1.49
High today$1.49
Low today
$1.44
Low today$1.44
Open price
$1.44
Open price$1.44
Volume
71.86K
Volume71.86K
52 Week high
$2.45
52 Week high$2.45
52 Week low
$0.73
52 Week low$0.73

Stock Snapshot

The current MIRA Pharmaceuticals(MIRA) stock price is $1.45, with a market capitalization of 61.26M. The stock trades at a price-to-earnings (P/E) ratio of -0.96.

As of 2026-01-18, MIRA Pharmaceuticals(MIRA) stock has fluctuated between $1.44 and $1.49. The current price stands at $1.45, placing the stock +0.7% above today's low and -2.7% off the high.

The MIRA Pharmaceuticals(MIRA)'s current trading volume is 71.86K, compared to an average daily volume of 126.48K.

During the past year, MIRA Pharmaceuticals(MIRA) stock moved between $0.73 at its lowest and $2.45 at its peak.

During the past year, MIRA Pharmaceuticals(MIRA) stock moved between $0.73 at its lowest and $2.45 at its peak.

People also own

Based on the portfolios of people who own MIRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .